Joanne Curley Ph.D.
Net Worth
Last updated:
What is Joanne Curley Ph.D. net worth?
The estimated net worth of Dr. Joanne Curley Ph.D. is at least $2,802,768 as of 21 Aug 2023. He owns shares worth $588,041 as insider, has earned $868,477 from insider trading and has received compensation worth at least $1,346,250 in Vera Therapeutics, Inc..
What is the salary of Joanne Curley Ph.D.?
Dr. Joanne Curley Ph.D. salary is $448,750 per year as Chief Devel. Officer in Vera Therapeutics, Inc..
How old is Joanne Curley Ph.D.?
Dr. Joanne Curley Ph.D. is 56 years old, born in 1969.
What stocks does Joanne Curley Ph.D. currently own?
As insider, Dr. Joanne Curley Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Vera Therapeutics, Inc. (VERA) | Chief Devel. Officer | 26,962 | $21.81 | $588,041 |
What does Vera Therapeutics, Inc. do?
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Joanne Curley Ph.D. insider trading
Vera Therapeutics, Inc.
Dr. Joanne Curley Ph.D. has made 25 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,490 units of VERA stock worth $24,817 on 21 Aug 2023.
The largest trade he's ever made was exercising 12,426 units of VERA stock on 20 Sep 2022. As of 21 Aug 2023 he still owns at least 26,962 units of VERA stock.
Vera Therapeutics key executives
Vera Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Joanne Curley Ph.D. (56) Chief Devel. Officer
- Dr. Marshall Fordyce M.D. (51) Founder, Pres, Chief Executive Officer & Director